Terbinafine indications and usage: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Terbinafine}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TERBINAFINE (TERBINAFINE HYDROCHLORIDE) TABLET [...") |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==Indications and Usage== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TERBINAFINE (TERBINAFINE HYDROCHLORIDE) TABLET [AUROBINDO PHARMA LIMITED] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6600e2b3-65df-4fc3-8081-d574537d27e3 | publisher = | date = | accessdate = }}</ref> | *:'''[[onychomycosis]] of the toenail''' | ||
*:'''fingernail due to [[dermatophytes]]''' (tinea unguium) | |||
'''Prior to initiating treatment''' | |||
Appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of [[onychomycosis]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TERBINAFINE (TERBINAFINE HYDROCHLORIDE) TABLET [AUROBINDO PHARMA LIMITED] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6600e2b3-65df-4fc3-8081-d574537d27e3 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 23:42, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Indications and Usage
- onychomycosis of the toenail
- fingernail due to dermatophytes (tinea unguium)
Prior to initiating treatment
Appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis.[1]
References
Adapted from the FDA Package Insert.